Clinical Scorecard: The CRISPR-powered Diagnostic SLEUTH

At a Glance

Key Highlights

• Modified CRISPR–Cas12a system uses DNA guides for RNA detection
• Accurate recognition and cleavage of single-stranded RNA
• Diagnostic workflow SLEUTH shows complete agreement with RT-qPCR
• System can distinguish single-nucleotide sequence differences
• Demonstrated targeted RNA reduction in living cells

Guideline-Based Recommendations

Diagnosis

• Use of DNA-guided Cas12a for RNA-targeted diagnostics

Management

• Applications in mutation detection and precision diagnostics

Monitoring & Follow-up

• Further optimization of the DNA-guided system is required

Risks

• Less stability of DNA-guided complexes compared to RNA-guided systems

Patient & Prescribing Data

SARS-CoV-2 clinical samples

RNA-targeted therapies using DNA guides

Clinical Best Practices

• Consider DNA-guided systems for RNA detection in diagnostics
• Evaluate stability and efficacy in clinical settings

Related Resources & Content

• Nature Biotechnology Study